EPRT financial statements and SEC filings
EPRT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $561.22M | $359.92M | $252.12M | 10-K |
| 2024-12-31 | $449.61M | $278.19M | $202.53M | 10-K |
| 2023-12-31 | $359.60M | $242.75M | $190.30M | 10-K |
| 2022-12-31 | $286.51M | $175.42M | $133.76M | 10-K |
| 2021-12-31 | $230.23M | $134.42M | $95.41M | 10-K |
| 2020-12-31 | $164.01M | $72.83M | $41.87M | 10-K |
EPRT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $6.86B | $2.66B | $4.21B | 10-Q |
| 2024-12-31 | $5.80B | $2.23B | $3.57B | 10-K |
| 2023-12-31 | $4.77B | $1.78B | $2.99B | 10-K |
| 2022-12-31 | $4.00B | $1.50B | $2.50B | 10-K |
| 2021-12-31 | $3.30B | $1.25B | $2.04B | 10-K |
| 2020-12-31 | $2.49B | $906.85M | $1.58B | 10-K |
EPRT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $381.08M | – | $798.35M | 10-K |
| 2024-12-31 | $308.48M | – | $810.70M | 10-K |
| 2023-12-31 | $254.57M | – | $580.01M | 10-K |
| 2022-12-31 | $211.02M | – | $506.80M | 10-K |
| 2021-12-31 | $167.39M | – | $689.06M | 10-K |
| 2020-12-31 | $99.39M | – | $457.79M | 10-K |